Osteoporosis drugs on every 2026 California Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in California cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
12 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | HealthSpring Assurance Rx$0.00/moS5617-158 | Wellcare Value Script$5.70/moS4802-163 | Wellcare Classic$6.20/moS4802-094 | HealthSpring Extra Rx$70.60/moS5617-382 | SilverScript Choice$103.60/moS5601-064 | Humana Value Rx Plan$104.60/moS5884-211 | AARP Medicare Rx Saver from UHC$109.40/moS5921-376 | Humana Basic Rx Plan$132.20/moS5884-114 | AARP Medicare Rx Preferred from UHC$165.40/moS5921-413 | Humana Premier Rx Plan$172.90/moS5884-178 | Blue Shield Rx Plus$199.70/moS2468-003 | Blue Shield Rx Enhanced$227.80/moS2468-004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| alendronategeneric Fosamax | Tier 15%QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00 | Tier 1$0.00 | Tier 1$0.00QL 30/30d | Tier 2$7.00QL 30/30d | Tier 2$1.00QL 30/30d | Tier 1$5.00QL 30/30d | Tier 1$0.00QL 30/30d | Tier 1$0.00 | Tier 1$0.00 |
| risedronategeneric Actonel | Not covered | Tier 2$3.00QL 1/30d | Not covered | Not covered | Tier 433%QL 1/28d | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| ibandronategeneric Boniva | Tier 325%QL 1/28d | Tier 2$3.00QL 1/30d | Tier 325%QL 1/30d | Tier 317%QL 1/28d | Tier 433%QL 1/30d | Tier 318%QL 1/28d | Tier 317%QL 1/28d | Tier 325%QL 1/28d | Tier 315%QL 1/28d | Tier 3$45.00QL 1/28d | Tier 2$7.00 | Tier 1$0.00 |
| Proliadenosumab | Tier 429%QL 1/180d | Not covered | Not covered | Tier 430%QL 1/180d | Not covered | Tier 432%QL 1/180d | Not covered | Tier 432%QL 1/180d | Not covered | Tier 450%QL 1/180d | Not covered | Not covered |
| denosumab biosimilarsJubbonti, Ospomyv and others | Not covered | Tier 440%QL 1/180d | Tier 431%QL 1/180d | Not covered | Tier 433%QL 1/180d | Not covered | Tier 438%QL 1/180d | Not covered | Tier 431%QL 1/180d | Not covered | Tier 4PA49% | Tier 4PA37% |
| Evenityromosozumab | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Forteoteriparatide | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 5PA26%QL 2.24/28d | Not covered | Tier 5PA25%QL 2.24/28d | Not covered | Tier 5PA33%QL 2.24/28d | Not covered | Not covered |
| teriparatidegeneric Forteo | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Tier 5PA25%QL 2.48/28d | Tier 5PA25% | Not covered | Tier 5PA25%QL 2.48/28d | Not covered | Tier 5PA31%QL 2.48/28d | Not covered | Tier 5PA25% | Tier 5PA33% |
| Tymlosabaloparatide | Not covered | Not covered | Not covered | Not covered | Tier 5PA25% | Not covered | Not covered | Not covered | Tier 5PA31%QL 1.56/30d | Not covered | Tier 5PA25%QL 1.56/28d | Tier 5PA33%QL 1.56/28d |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.